...
首页> 外文期刊>ACS applied materials & interfaces >A pH-Controlled Kit for Total and Direct Bilirubin Built on Mimetic Peroxidase CoFe2O4-DOPA-Catalyzed Fluorescence Enhancement
【24h】

A pH-Controlled Kit for Total and Direct Bilirubin Built on Mimetic Peroxidase CoFe2O4-DOPA-Catalyzed Fluorescence Enhancement

机译:用于总共和直接胆红素的pH控制试剂盒,基于模拟过氧化物酶COFE2O4-DOPA催化的荧光增强

获取原文
获取原文并翻译 | 示例
           

摘要

Facile and reliable detection of total bilirubin (Bt, summation of indirect and direct bilirubin) and direct bilirubin (Bd) in human serum is of crucial importance to clinical diagnosis. However, it is still a challenge to explore an ideal recognition system for discriminating Bd and indirect bilirubin (Bi). In this work, a dual-functional sensor for Bt and Bd was first built on pH-controlled and mimetic peroxidase-catalyzed fluorescence enhancement. The fluorescence of nitrogen-doped graphene quantum dots (NGQDs) can be effectively quenched by bilirubin through the IFE process. With the catalysis of dopamine-derived magnetic ferrite nanoparticles (CoFe2O4-DOPA), both Bd and Bi were oxidized by H2O2 to colorless and fluorescent oxidates at pH 8.0. Interestingly, only Bd was oxidized at pH 3.5. The discriminating principle of Bd and Bi relied on their pH-controlled oxidation potentials. A sensitive sensor for Bt and Bd was developed on the enhanced fluorescence of the NGQDs/CoFe(2)O(4)DOPA/H2O2O sensing system after bilirubin oxidation, which was originated from a combination of the fluorescence recovery of NGQDs and newly spawned fluorescence of bilirubin oxidates. The designed probe well quantifies Bt and Bd with the detection limits of 10 and 50 nM, respectively. Moreover, a portable diagnostic kit was fabricated and successfully used for the detection of Bt and Bd in 60 unrelated human serum samples, and the obtained results were almost consistent with those measured by biochemistry analyzer. The present kit exhibits the superiorities of high sensitivity and stability, interference-resistant, and green reagents, making it a promising candidate for bilirubin detection in the clinical diagnosis of jaundice.
机译:体内胆红素(间接和直接胆红素的BT,Submation)和人类血清中的直接胆红素(BD)的胆红素(Bt,Submation)以及对临床诊断至关重要的可靠性和可靠的检测。然而,探索鉴别BD和间接胆红素(BI)的理想识别系统仍然是一项挑战。在这项工作中,首先基于pH控制和模拟过氧化物酶催化的荧光增强,首先是BT和BD的双功能传感器。通过IFE法,可以通过胆红素有效地淬灭氮掺杂石墨烯量子点(NgQDS)的荧光。随着多巴胺衍生的磁性铁氧体纳米颗粒(CoFe2O4-DoPA)的催化,Bd和Bi均通过H 2 O 2氧化至pH8.0的无色和荧光氧化物。有趣的是,只有BD在pH 3.5氧化。 BD和BI的区别原理依赖于其pH控制的氧化潜力。在胆红素氧化后的NgQDS / CoFe(2)O(4)O(4)多孔(2)O(4)o(4)o(4)O(4)o(4)o(4)o(4)o(4)o(4)o(4)o(4)o(4)O(4)多孔/ H2O2o感测系统的增强荧光荧光,其源自NgQDS的荧光回收和新生产荧光的组合胆红素氧化物。设计的探头阱分别定量了BT和BD,分别具有10和50nm的检测限。此外,制造了便携式诊断试剂盒并成功地用于在60个不相关的人血清样品中检测BT和BD,并且获得的结果几乎与通过生物化学分析仪测量的结果一致。目前的套件表现出高灵敏度和稳定性,抗干扰和绿色试剂的优越性,使其成为胆红素检测的有希望的胆红素检测的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号